03953nam a2200385zi 45000010014000000030008000140050017000220070003000390080041000420200037000830200034001200400031001540720016001850720015002010720015002162450104002312640054003352640079003893360021004683370025004893380023005143650110005373660044006474900025006915000026007165050947007425200953016895450721026426500034033636500033033976500033034307000035034637000033034987000036035319781849841757UK-WkNB20230418000000.0ta230418e202403uuxxk    | |||||||0|0 eng|d  a9781849841757 (pbk.) :cEUR60.00  a1849841756 (pbk.) :cEUR60.00  aUK-WkNBbengcUK-WkNBerda 7aMJL2bicssc 7aHEA2ukslc 7aMJL2thema10aCOPD in the 21st Century /cEdited by Jadwiga A. Wedzicha, James P. Allinson, Peter M.A. Calverley. 1aSheffield :bEuropean Respiratory Society,c2024. 2aGB :bEuropean Respiratory Society,c[date of distribution not identified]  atext2rdacontent  aunmediated2rdamedia  avolume2rdacarrier  a02b60.00cEURd00eThis price includes a tax elementhZ 60.00 0.00 60.00 0.00jGBkxxkmTEDITOR2onix-pt  b20240301cIP 20240321jGBkxxk2UK-WkNB0 aERS Monograph ;v103  aPaperback / softback.0 aThe patients’ perspective on living with COPD and their priorities for future research and care-- COPD as the new millennium began-- Defining COPD in the 21st century-- A new understanding of the natural history of COPD-- The new epidemiology of COPD-- Cardiac comorbidity and COPD: chance or consequence?-- Mechanisms and medicators of disease-- The microbiome and COPD-- Chronic bronchitis revisited-- Eosinophils and COPD-- Advances in the characterisation of COPD using quantitative imaging-- New physiological measurements in COPD-- Guidelines and strategies of management-- Current pharmacotherapy of COPD-- The future drug treatment of COPD-- The future of pulmonary rehabilitation in COPD-- New insights into the pathophysiology and epidemiology of COPD exacerbations-- Managing exacerbations of COPD: how much progress have we made?-- Noninvasive ventilation in COPD-- Lung volume reduction for emphysema-- COPD at a tipping point.  aThis Monograph provides an up-to-date overview of what is happening in this exciting field, both at a basic and a clinical level.bCOPD remains a major cause of ill health, disability, healthcare costs and premature mortality. Scientists and clinicians across many countries have made great efforts to understand this important disease, and these have yielded positive results. This Monograph provides an up-to-date overview of what is happening in this exciting field, both at a basic and a clinical level. Beginning, crucially, with the patient’s perspective, the chapters that follow consider the best way to define COPD, changes in the disease’s incidence and prevalence, and offer new insights into the role of the microbiome in COPD, advances in imaging and treatment options, both pharmacological and non-pharmacological. Taken together, these chapters are an important contribution to the Monograph series and the COPD field in general.0 aJadwiga A. Wedzicha is Professor of Respiratory Medicine, Head of the Respiratory Division at the National Heart and Lung Institute (Imperial College London, London, UK), Consul at Imperial College and Honorary Consultant at the Royal Brompton and Harefield Hospitals (London, UK). James P. Allinson is Consultant Respiratory Physician at the Royal Brompton Hospital (London, UK) and an honorary Senior Clinical Lecturer at the National Heart and Lung Institute (Imperial College London, London, UK). Peter M.A. Calverley is Emeritus Professor of Respiratory Medicine at the University of Liverpool (Liverpool, UK) and continues to work in the Institute of Life Courses and Medical Science (University of Liverpool). 7aRespiratory medicine.2bicssc 7aHealth and Wellbeing.2ukslc 7aRespiratory medicine.2thema1 aWedzicha, Jadwiga A.,eeditor.1 aAllinson, James P.,eeditor.1 aCalverley, Peter M.A.,eeditor.